Merrimack Pharmaceuticals | Spese Operative



Operating Expenses Cambiamento Data
Bioline Rx USD 2.65M 13.53M 2025-03
Celldex Therapeutics USD 63.43M 6.23M 2025-03
Incyte USD 847.73M 29.46M 2025-03
Roche Holding CHF 11.43B 1.48B 2024-12
Sanofi EUR 6.77B 3.75B 2024-12



Merrimack Pharmaceuticals Spese Operative - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Jul 2025.